39 related articles for article (PubMed ID: 12204956)
1. In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.
Ampel NM; Kramer LA; Li L; Carroll DS; Kerekes KM; Johnson SM; Pappagianis D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1039-43. PubMed ID: 12204956
[TBL] [Abstract][Full Text] [Related]
2. The mannose receptor mediates the cellular immune response in human coccidioidomycosis.
Ampel NM; Nelson DK; Li L; Dionne SO; Lake DF; Simmons KA; Pappagianis D
Infect Immun; 2005 Apr; 73(4):2554-5. PubMed ID: 15784604
[TBL] [Abstract][Full Text] [Related]
3. PREVALENCE OF ATOPIC DISORDERS AMONG PEDIATRIC PATIENTS WITH PULMONARY AND DISSEMINATED COCCIDIOIDOMYCOSIS.
Zhang S; LaBere B; Woodward JV; Ballan W; Perry KW; Sacco K
Pediatr Infect Dis J; 2024 Mar; ():. PubMed ID: 38535089
[TBL] [Abstract][Full Text] [Related]
4. Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Shubitz LF; Robb EJ; Powell DA; Bowen RA; Bosco-Lauth A; Hartwig A; Porter SM; Trinh H; Moale H; Bielefeldt-Ohmann H; Hoskinson J; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2021 Nov; 39(47):6894-6901. PubMed ID: 34696935
[TBL] [Abstract][Full Text] [Related]
5.
Ampel NM; Robey I; Nguyen CT; Roller B; August J; Knox KS; Pappagianis D
mSphere; 2018; 3(3):. PubMed ID: 29769377
[TBL] [Abstract][Full Text] [Related]
6. The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.
Kirkland TN
J Fungi (Basel); 2016 Dec; 2(4):. PubMed ID: 29376949
[TBL] [Abstract][Full Text] [Related]
7. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.
Ampel NM; Nesbit LA; Nguyen CT; Chavez S; Knox KS; Johnson SM; Pappagianis D
Clin Vaccine Immunol; 2015 Aug; 22(8):917-22. PubMed ID: 26041038
[TBL] [Abstract][Full Text] [Related]
9. Distance from construction site and risk for coccidioidomycosis, Arizona, USA.
Blair JE; Chang YH; Ruiz Y; Duffy S; Heinrich BE; Lake DF
Emerg Infect Dis; 2014 Sep; 20(9):1464-71. PubMed ID: 25148473
[TBL] [Abstract][Full Text] [Related]
10. Valley fever: danger lurking in a dust cloud.
Johnson L; Gaab EM; Sanchez J; Bui PQ; Nobile CJ; Hoyer KK; Peterson MW; Ojcius DM
Microbes Infect; 2014 Aug; 16(8):591-600. PubMed ID: 25038397
[TBL] [Abstract][Full Text] [Related]
11. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
12. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
[TBL] [Abstract][Full Text] [Related]
13. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.
Blair JE; Coakley B; Santelli AC; Hentz JG; Wengenack NL
Mycopathologia; 2006 Nov; 162(5):317-24. PubMed ID: 17123029
[TBL] [Abstract][Full Text] [Related]
14. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation.
Dionne SO; Podany AB; Ruiz YW; Ampel NM; Galgiani JN; Lake DF
Infect Immun; 2006 Apr; 74(4):2415-22. PubMed ID: 16552071
[TBL] [Abstract][Full Text] [Related]
15. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
16. An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.
Ampel NM; Hector RF; Lindan CP; Rutherford GW
Mycopathologia; 2006 Feb; 161(2):67-72. PubMed ID: 16463089
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis.
Li L; Dial SM; Schmelz M; Rennels MA; Ampel NM
Infect Immun; 2005 Jul; 73(7):3923-8. PubMed ID: 15972478
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.
Ampel NM; Nelson DK; Chavez S; Naus KA; Herman AB; Li L; Simmons KA; Pappagianis D
Clin Diagn Lab Immunol; 2005 Jun; 12(6):700-4. PubMed ID: 15939743
[TBL] [Abstract][Full Text] [Related]
19. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
20. Measurement of cellular immunity in human coccidioidomycosis.
Ampel NM
Mycopathologia; 2003; 156(4):247-62. PubMed ID: 14682448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
